The product contains hemoglobin molecules from expired donor blood, which are encapsulated in protective lipid shells.

World- First Discovery by Sydney Scientists Reveals the Hidden Cause of Organ Damage in COVID-19 and Other Deadly ConditionsAustralian researchers ...

Researchers at Stanford have developed a new technology for removing blood clots that is more than twice as effective as ...

By reprogramming brain cells, a new gene therapy approach for Alzheimer's developed by UC San Diego researchers could address ...

Vitamin B12, or cobalamin, is crucial for energy production, nerve health, and a robust immune system. It boosts white blood ...

Is red light therapy the holy grail of holistic health remedies, or is it a scam? I took a deep dive to discover the benefits ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell disease: Paris Thursday, June 5, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ( ...

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...

When treating an ischemic stroke – where a clot is blocking the flow of oxygen to the brain – every minute counts.

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease <li /> Fourth orphan drug designation for rilzabrutinib ...

Over the past five or 10 years, methylene blue has come to be touted online as a so-called nootropic agent – a substance that ...